ENTITY
Cathay Biotech

Cathay Biotech (688065 CH)

37
Analysis
MaterialsChina
Cathay Biotech Inc. engages in synthetic biology, producing new materials on an industrial scale through bio-manufacturing. The Company focuses on polyamide industry's value chain covering biological long-chain dibasic acid, bio-based pentane diamine, bio-based polyamide, and more. Cathay Biotech markets its products worldwide.
more
Refresh
22 Jan 2024 06:10

CSI300 Index Rebalance Preview: A Dozen Changes for June

We forecast 12 changes for the CSI300 Index in June with a one-way turnover of 1.3% and one-way trade of US$703m. The potential adds have...

Logo
489 Views
Share
06 Dec 2023 11:40

Quiddity Aggregation of CSI300/500 and SSE50/180 Index Flows for Dec 2023: US$4.2bn One-Way!

Large Mainland China index flows coming up. I expect the CSI300/500 and the SSE50/180 Inclusion and Exclusion events to take place at the close of...

Share
26 Nov 2023 11:00

CSI300 Index Rebalance: 14 Changes & A Few Surprises

There are 14 changes for the CSI300 in December. Most of the changes were expected and there are a few surprises as the index committee has...

Logo
918 Views
Share
14 Nov 2023 05:30

CSI300 Index Rebalance Preview: 13 Potential Changes in December

There could be 13 changes for the CSI300 in Dec. With an increase in tracking AUM, there are many stocks with over 1x ADV to trade. Adds, deletes...

Logo
709 Views
Share
17 Sep 2023 06:01

Quiddity Leaderboard CSI 300/​​500 Dec 23:  US$2.8bn One-Way; Might Be Time for a Basket Trade

The Names directly moving into CSI 300 and CSI 500 without previously being members of either of these indices could outperform the CSI 300 index...

Share
x